Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

Share Price is delayed by 15 minutes
Get Live Data
8.65    0.00 (0.00%)
Bid:
8.30
Ask:
9.00
Spread: 0.70 (8.434%)
Market Cap: £18.86m
IXI Live PriceLast checked at - London Stock Exchange

Intraday Ixico Share Chart

PDMR Transaction

25 Mar 2021 09:14

RNS Number : 4793T
IXICO plc
25 March 2021
Β 

25 March 2021

Β 

IXICO plc

("IXICO" or the "Company")

Β 

Director/PDMR Dealing

Β 

Β 

IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that Mark Warne, Non-Executive Director, today purchased 14,250 ordinary shares in the Company at an average price of 63 pence.

Β 

Β 

For further information please contact:

Β 

IXICO plc +44 20 3763 7499

Giulio Cerroni, Chief Executive Officer

Grant Nash, Chief Financial Officer

Β 

Cenkos Securities plc (Nominated adviser and sole broker) +44 20 7397 8900

Giles Balleny / Max Gould (Corporate Finance)

Michael F Johnson / Russell Kerr (Sales)

Β 

Walbrook PR Ltd

+44 (0)20 7933 8780

Β 

Paul McManus / Lianne Cawthorne /

IXICO@walbrookpr.com

Alice Woodings

Β 

The below makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Mark Warne

2

Reason for notification

On market purchase

a.

Position/Status

Non-Executive Director

b.

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

IXICO plc

b.

LEI

2138005M1F59O6HWSA97

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary shares of 1p each

ISIN: GB00BCLY7L40

Β 

b.

Nature of the transaction

Β Purchase of ordinary shares

c.

Price(s) and volume(s)

Price(s) per share

Volume(s)

Β£0.66

250 shares

Β£0.64

1500 shares

Β£0.65

1500 shares

Β£0.63

1500 shares

Β£0.61

1500 shares

Β£0.61

1500 shares

Β£0.63

1500 shares

Β£0.62

5000 shares

Β 

Β 

d.

Aggregated information

- Aggregated Volume

- Price

Β 

14,250 shares

Β£0.63

e.

Date of the transaction

24 March 2021

f.

Place of the transaction

London Stock Exchange, AIM Market

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHKELBLFXLBBBK
Date   Source Headline
19th Jan 20112:14 pmRNSDirector/PDMR Shareholding
14th Jan 201110:18 amRNSHolding(s) in Company
10th Jan 201111:45 amRNSHolding(s) in Company
7th Jan 20111:50 pmRNSBlock Listing Application
7th Jan 201110:59 amRNSBlocklisting Application
4th Jan 20112:01 pmRNSTotal Voting Rights
21st Dec 201012:19 pmRNSDirector/PDMR Shareholding
21st Dec 201012:18 pmRNSDirector/PDMR Shareholding
14th Dec 20101:15 pmRNSBlock Listing Application
30th Nov 20107:00 amRNSFinal Results
17th Nov 201011:44 amRNSResearch Update
3rd Nov 20109:29 amRNSBlocklisting Interim Review
1st Nov 20104:31 pmRNSPreliminary Results - Change of Date
1st Nov 201010:41 amRNSNotice of Results
29th Sep 20102:00 pmRNSPresents Cogane data at scientific conferences
18th Aug 20107:00 amRNSInterim Management Statement
22nd Jul 20101:49 pmRNSDirector/PDMR Shareholding
22nd Jul 20101:49 pmRNSDirector/PDMR Shareholding
5th Jul 201010:59 amRNSChange of Registered Office
21st Jun 20107:00 amRNSAppointment of Chief Executive Officer
14th Jun 20107:00 amRNSRegulatory Approval to Begin Cogane PII Trial
24th May 20107:00 amRNSHalf Yearly Report
19th May 20104:25 pmRNSNotice of Results
4th May 20102:13 pmRNSBlocklisting Interim Review
1st Apr 201012:36 pmRNSDirector/PDMR Shareholding
1st Apr 201012:35 pmRNSDirector/PDMR Shareholding
1st Apr 201012:34 pmRNSDirector/PDMR Shareholding
31st Mar 201012:19 pmRNSResult of AGM
2nd Mar 20108:25 amRNSNotice of AGM
11th Feb 20107:00 amRNSInterim Management Statement
15th Jan 20107:00 amRNSDirectorate Change
5th Jan 20109:10 amRNSHolding(s) in Company
4th Jan 201010:29 amRNSTotal Voting Rights
31st Dec 20099:26 amRNSDirector/PDMR Shareholding
31st Dec 20099:25 amRNSDirector/PDMR Shareholding
31st Dec 20099:25 amRNSDirector/PDMR Shareholding
31st Dec 20099:25 amRNSDirector/PDMR Shareholding
29th Dec 20093:27 pmRNSResult of EGM
22nd Dec 20097:00 amRNSResult of Open Offer
15th Dec 20093:12 pmRNSCorrection to the Form of Proxy
15th Dec 20099:00 amRNSAnnual Information Update
14th Dec 20097:00 amRNSPresents data at XVIII WFN World Congress
3rd Dec 20095:18 pmRNSPublication of Prospectus
3rd Dec 20097:05 amRNSPlacing and Open Offer to Raise ?25.2 million
3rd Dec 20097:00 amRNSReport and Accounts 2009 - Part 3
3rd Dec 20097:00 amRNSReport and Accounts 2009 - Part 2
3rd Dec 20097:00 amRNSReport and Accounts 2009 - Part 1
12th Nov 20093:59 pmRNSBlocklisting Interim Review
4th Nov 20091:36 pmRNSHolding(s) in Company
23rd Oct 20099:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.